ITOCNasdaqElectromedical & Electrotherapeutic Apparatus
iTonic Holdings Ltd
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 30, 2026
$3.71−0.13 (-3.39%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
iTonic Holdings Ltd revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | % of revenue | YoY |
|---|---|---|---|---|---|---|
| Sales of FTTPS [Member] | $362.85K | $369.55K | $609.35K | $668.68K | 69.4% | -1.8% |
| Sales of Medical Auxiliary Supplies [Member] | $160.18K | $78.65K | $19.24K | $11.10K | 30.6% | +103.7% |
| Contract Liabilities [Member] | $31.64K | $28.67K | $132.66K | – | 6.0% | +10.4% |
By region
From the segment and revenue-disaggregation notes of iTonic's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.